Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1176-2013Class II

ORTHOCORD One Violet and One Blue Braided Composite Suture with OS-6 Reverse Cutting Needles

DePuy Mitek, Inc. / initiated 2013-03-22 / Terminated / root cause: labeling and UDI

DePuy Mitek, Inc., a Johnson & Johnson Co. began a recall of ORTHOCORD One Violet and One Blue Braided Composite Suture with OS-6 Reverse Cutting Needles, Product Code: 223116. For use in general soft tissue... on . FDA classified it as Class II and gives the reason as "The IFU provided with the free strand ORTHOCORD sutures currently indicates that approximately 100% suture strength remains at six weeks after implantation. While this statement is true for Violet ORTHOCORD sutures, it...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1176-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
DePuy Mitek, Inc.
Product
ORTHOCORD One Violet and One Blue Braided Composite Suture with OS-6 Reverse Cutting Needles, Product Code: 223116. For use in general soft tissue approximation, and/or ligation, including orthopedic procedures.
Product code
NEW Suture, Surgical, Absorbable, Polydioxanone
Reason for recall
The IFU provided with the free strand ORTHOCORD sutures currently indicates that approximately 100% suture strength remains at six weeks after implantation. While this statement is true for Violet ORTHOCORD sutures, it is an inaccurate statement for Blue ORTHOCORD free strand sutures. Based on in-vivo strength retention study, a Blue ORTHOCORD sutures maintain approximately 80% of strength at six
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
On March 22, 2013, firm notified consignees of recall via letter. Consignees were informed of the following: The IFU provided with the free strand ORTHOCORD sutures currently indicates that approximately 100% suture strength remains at six weeks after implantation. While this statement is true for Violet ORTHOCORD sutures, it is an inaccurate statement for Blue ORTHOCORD free strand sutures. Based on in-vivo strength retention study, a Blue ORTHOCORD sutures maintain approximately 80% of strength at six weeks after implantation. As Blue and Violet ORTHOCORD free strand sutures share the same IFU, IFU-108147 will be revised. Consignees were requested to confirm the receipt of the letter by March 29, 2013.
Quantity in commerce
46501
Distribution
Nationwide Distribution.
Product codes and lots
ALL from Jan 1 2010 - Corrected IFU implementation date

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1176-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1172-2013Class IITerminatedVoluntary: Firm initiated
Z-1173-2013Class IITerminatedVoluntary: Firm initiated
Z-1174-2013Class IITerminatedVoluntary: Firm initiated
Z-1175-2013Class IITerminatedVoluntary: Firm initiated
Z-1176-2013Class IITerminatedVoluntary: Firm initiated